Advertisement
Advertisement
Trending on Urology Times
1
Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer
2
Community practice experience shows early efficacy, favorable safety with nadofaragene
3
ORIC-944 shows promise in combination with ARPIs for mCRPC
4
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
5
